MX349003B - Metodo para la deteccion del asociado de union libre de un aglutinante multiespecifico. - Google Patents

Metodo para la deteccion del asociado de union libre de un aglutinante multiespecifico.

Info

Publication number
MX349003B
MX349003B MX2014007095A MX2014007095A MX349003B MX 349003 B MX349003 B MX 349003B MX 2014007095 A MX2014007095 A MX 2014007095A MX 2014007095 A MX2014007095 A MX 2014007095A MX 349003 B MX349003 B MX 349003B
Authority
MX
Mexico
Prior art keywords
detection
binding partner
free binding
multispecific antibody
multispecific binder
Prior art date
Application number
MX2014007095A
Other languages
English (en)
Other versions
MX2014007095A (es
Inventor
Stubenrauch Kay-Gunnar
Wessels Uwe
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2014007095A publication Critical patent/MX2014007095A/es
Publication of MX349003B publication Critical patent/MX349003B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a un método in vitro para la determinación de la presencia y/o cantidad de un antígeno de un anticuerpo multiespecífico en una muestra, mientras el antígeno a ser detectado puede estar específicamente unido por una primera especificidad del anticuerpo multiespecífico, caracterizado porque comprende los pasos de; -incubar la muestra que comprende el anticuerpo multiespecífico, anticuerpo unido al anticuerpo multiespecífico y el antígeno libre con un anticuerpo anti-idiotípico que específica se une a una segunda especificidad del anticuerpo multiespecífico, que es diferente de la primera especificidad de unión, -agotar el complejo de anticuerpo anti-idiotípico-anticuerpo multiespecífico de la muestra antes de la determinación de la presencia y/o la cantidad de asociado de unión libre, y -determinar la presencia y/o la cantidad de antígeno libre en la muestra con anticuerpo multiespecífico agotado.
MX2014007095A 2011-12-19 2012-12-18 Metodo para la deteccion del asociado de union libre de un aglutinante multiespecifico. MX349003B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11194350 2011-12-19
PCT/EP2012/075991 WO2013092611A2 (en) 2011-12-19 2012-12-18 Method for the detection of free binding partner of a multispecific binder

Publications (2)

Publication Number Publication Date
MX2014007095A MX2014007095A (es) 2014-07-22
MX349003B true MX349003B (es) 2017-07-06

Family

ID=47429825

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014007095A MX349003B (es) 2011-12-19 2012-12-18 Metodo para la deteccion del asociado de union libre de un aglutinante multiespecifico.

Country Status (10)

Country Link
US (1) US9671394B2 (es)
EP (1) EP2795335B1 (es)
JP (1) JP6203747B2 (es)
KR (1) KR20140099277A (es)
CN (1) CN104040350B (es)
BR (1) BR112014011535A2 (es)
CA (1) CA2853917A1 (es)
MX (1) MX349003B (es)
RU (1) RU2633488C2 (es)
WO (1) WO2013092611A2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
JP2015507193A (ja) 2012-02-01 2015-03-05 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 多重特異性結合物の結合パートナーを検出するための方法
KR20150038046A (ko) 2012-07-13 2015-04-08 에프. 호프만-라 로슈 아게 다중특이적 결합체의 탐지 방법
CA2926306C (en) * 2013-11-05 2022-12-06 F. Hoffmann-La Roche Ag A method for determining the total amount and/or concentration of an analyte in a sample
WO2015143277A1 (en) * 2014-03-20 2015-09-24 Wellstat Diagnostics, Llc Antibodies and methods for the detection of cell death
WO2016097116A1 (en) * 2014-12-18 2016-06-23 Roche Diagnostics Gmbh Methods for reducing interferences
AU2018304711B2 (en) 2017-07-20 2025-04-10 Cytomx Therapeutics, Inc. Methods of qualitatively and/or quantitatively analyzing properties of activatable antibodies and uses thereof
CN109358192B (zh) * 2018-02-08 2020-05-12 中国科学院上海药物研究所 一种去除抗药抗体检测样品中游离药物的装置和方法、该装置的制备方法及应用
EP3805757A4 (en) 2018-06-04 2022-03-23 Chugai Seiyaku Kabushiki Kaisha Method for detecting complex
MX2021013519A (es) * 2019-05-13 2021-12-10 Regeneron Pharma Ensayos de union de ligandos competitivos mejorados.
EP3969907B1 (en) * 2019-05-13 2025-09-24 F. Hoffmann-La Roche AG Interference-suppressed pharmacokinetic immunoassay
CN117805397A (zh) * 2024-02-29 2024-04-02 军科正源（北京）药物研究有限责任公司 检测游离vegf的方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56128722A (en) * 1980-03-14 1981-10-08 Terumo Corp Removal of antiacetylcholinereceptor antibody and device therefor
US5219730A (en) 1982-09-28 1993-06-15 New York University Idiotype-anti-idiotype immunoassay
US4828981A (en) 1983-08-24 1989-05-09 Synbiotics Corporation Immunoassays for determining Dirofilaria immitis infection using antiidiotype monoclonal antibody reagents
EP0170302A1 (fr) 1984-06-27 1986-02-05 l'Association internationale à but scientifique, dite: Institut international de pathologie cellulaire et moléculaire Procédé de dosage immunologique d'une substance dans un échantillon liquide au moyen d'anticorps anti-idiotypiques
US4699880A (en) 1984-09-25 1987-10-13 Immunomedics, Inc. Method of producing monoclonal anti-idiotype antibody
US5238808A (en) 1984-10-31 1993-08-24 Igen, Inc. Luminescent metal chelate labels and means for detection
WO1987002778A1 (en) 1985-10-22 1987-05-07 Cooper-Lipotech Solid-phase liposome immunoassay system
US5068088A (en) 1988-11-03 1991-11-26 Igen, Inc. Method and apparatus for conducting electrochemiluminescent measurements
KR0143993B1 (ko) 1988-11-03 1998-07-15 리차아드 제이 매씨이 전기화학 발광성 분석
IL100866A (en) 1991-02-06 1995-10-31 Igen Inc Method and apparatus for magnetic microparticulate based luminescence assay including plurality of magnets
ATE225801T1 (de) 1992-07-13 2002-10-15 Bionebraska Inc Verfahren zur modifizierung rekombinanter polypeptide
GB9316369D0 (en) * 1993-08-06 1993-09-22 Surface Active Ltd Diagnostic method
US6753189B1 (en) * 1998-06-04 2004-06-22 Mizuho Medy Co., Ltd. Detection apparatus and method for the same
JPH11352129A (ja) * 1998-06-04 1999-12-24 Mizuho Medeii:Kk 検出装置及び検出方法
JP4620312B2 (ja) * 1999-11-16 2011-01-26 ジェネンテック， インコーポレイテッド Ｖｅｇｆに対するエライザ
EP1288308A1 (en) * 2001-08-28 2003-03-05 Roche Diagnostics GmbH A method for the determination of multiple analytes
GB0320459D0 (en) 2003-09-01 2003-10-01 Selective Antibodies Ltd Assay methods and materials
DE102004052729A1 (de) * 2004-10-30 2006-05-04 Roche Diagnostics Gmbh Immunkomplex-spezifsicher Antikörper zur Reduktion des Nullwerts beim Nachweis von Antigen-spezifisch gebundenen Antikörpern einer bestimmten Immunglobulinklasse in Array-Testformaten
WO2006096697A2 (en) 2005-03-08 2006-09-14 Tanox, Inc. Methods for determining the bivalency of protein and antibody therapeutics
SI2457929T1 (sl) * 2006-10-04 2016-09-30 Genentech, Inc. ELISA za VEGF
EP1917854A1 (en) 2006-11-06 2008-05-07 F. Hoffmann-La Roche Ag Method for producing anti idiotypic antibodies
US20090162359A1 (en) 2007-12-21 2009-06-25 Christian Klein Bivalent, bispecific antibodies
US8242247B2 (en) 2007-12-21 2012-08-14 Hoffmann-La Roche Inc. Bivalent, bispecific antibodies
US9266967B2 (en) 2007-12-21 2016-02-23 Hoffmann-La Roche, Inc. Bivalent, bispecific antibodies
US8227577B2 (en) 2007-12-21 2012-07-24 Hoffman-La Roche Inc. Bivalent, bispecific antibodies
CN102369215B (zh) 2009-04-02 2015-01-21 罗切格利卡特公司 包含全长抗体和单链Fab片段的多特异性抗体
DK2417156T3 (en) 2009-04-07 2015-03-02 Roche Glycart Ag Trivalent, bispecific antibodies
RU2570633C2 (ru) 2009-05-27 2015-12-10 Ф.Хоффманн-Ля Рош Аг Три- или тетраспецифические антитела
US9676845B2 (en) 2009-06-16 2017-06-13 Hoffmann-La Roche, Inc. Bispecific antigen binding proteins
US8703132B2 (en) 2009-06-18 2014-04-22 Hoffmann-La Roche, Inc. Bispecific, tetravalent antigen binding proteins
CN102207054B (zh) 2010-03-31 2013-03-13 比亚迪股份有限公司 一种混合动力车的爆震控制系统及方法
CN102207504A (zh) * 2011-03-23 2011-10-05 北京华创远航科技有限公司 一种酶联检测试剂盒及其制备方法

Also Published As

Publication number Publication date
US20150072359A1 (en) 2015-03-12
HK1201920A1 (zh) 2015-09-11
CN104040350B (zh) 2016-05-18
KR20140099277A (ko) 2014-08-11
RU2014128510A (ru) 2016-02-10
BR112014011535A2 (pt) 2017-05-09
EP2795335B1 (en) 2017-09-06
MX2014007095A (es) 2014-07-22
WO2013092611A3 (en) 2013-10-17
RU2633488C2 (ru) 2017-10-12
US9671394B2 (en) 2017-06-06
JP2015502547A (ja) 2015-01-22
WO2013092611A2 (en) 2013-06-27
CN104040350A (zh) 2014-09-10
JP6203747B2 (ja) 2017-09-27
CA2853917A1 (en) 2013-06-27
EP2795335A2 (en) 2014-10-29

Similar Documents

Publication Publication Date Title
MX349003B (es) Metodo para la deteccion del asociado de union libre de un aglutinante multiespecifico.
MX349661B (es) Metodo para la deteccion de una molecula de union de un enlazador multiespecifico.
BR112014012590A8 (pt) Anticorpos anti-cd98 e métodos de uso dos mesmos
GB201108236D0 (en) Method
MX2014014566A (es) Metodo para detectar un aglutinante multiespecifico.
ZA201207211B (en) Antibodies with ph dependent antigen binding
UA106070C2 (uk) Антитіло, що специфічно зв'язується з egfr і her3
UY34394A (es) Polipéptidos de anticuerpos que antagonizan cd40l
EP2788377A4 (en) HER3 ANTIBODIES AND USES THEREOF
SG11201402709WA (en) Method and device for assaying an antigen present on erythrocytes or an antibody binding to an antigen present on erythrocytes
EP3933406A3 (en) Antibodies to risperidone and use thereof
PH12015500751A1 (en) Anti-her3/her4 antigen binding proteins binding to the beta-hairpin of her3 and beta-hairpin of her4
GB201005191D0 (en) Immunoassays,methods for carrying out immunoassays,immunoassay kits and method for manufacturing immunoassay kits
AU2011285694A8 (en) Detection of degradation products of canine NT-proBNP
PH12015500752A1 (en) Her3 antigen binding proteins binding to the beta-hairpin of her3
MX353954B (es) Aptameros y metodos de diagnostico para detectar el receptor del factor de crecimiento epidermal (egf).
TR201910464T4 (tr) Bir fermuara yönelik durdurucu ve bunun üretimine ilişkin bir yöntem.
WO2012154983A3 (en) Systems and methods for anti-pax8 antibodies
EP2536817A4 (en) IMMUNOASSAY DEVICES FOR THE DETECTION OF ANTIBODIES AND ANTIGENES
JP2015502547A5 (es)
BR112012025082A2 (pt) novos anticorpos monoclonais e método de análise imunológica de dímero-d
WO2013181576A3 (en) Methods of evaluating and making biologics
NZ605449A (en) Anti-neuropilin antibodies and methods of use
WO2013175318A3 (en) Microbead agglutination based assays
EP2475383A4 (en) FOR THE PEPTIDE PRODUCED FROM HSP65 6 SPECIFIC HUMANIZED ANTIBODIES AND USES THEREOF

Legal Events

Date Code Title Description
FG Grant or registration